Immunic, Inc. (IMUX)
8.01
+0.26
(+3.35%)
USD |
NASDAQ |
Nov 09, 16:00
8.01
0.00 (0.00%)
After-Hours: 17:56
Immunic Gross Profit (Annual) : -0.168M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.168M |
| December 31, 2024 | -0.134M |
| December 31, 2023 | -0.111M |
| December 31, 2022 | -0.077M |
| December 31, 2021 | -0.085M |
| December 31, 2020 | -0.039M |
| December 31, 2019 | -0.05M |
| December 31, 2018 | -0.015M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.998M |
| December 31, 2016 | -1.808M |
| December 31, 2015 | -1.328M |
| December 31, 2014 | -1.087M |
| December 31, 2013 | -0.799M |
| December 31, 2012 | -0.651M |
| December 31, 2011 | -0.961M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| Sionna Therapeutics, Inc. | -0.647M |
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| Anika Therapeutics, Inc. | 63.81M |
| Savara, Inc. | -0.245M |